Current trends in drug treatment of obsessive–compulsive disorder

References

• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• EisenJLManceboMAPintoAImpact of obsessive-compulsive disorder on quality of lifeCompr Psychiatry200647427027516769301
   PubMed Web of Science ®Google Scholar
• FontenelleLFHaslerGThe analytical epidemiology of obsessive- compulsive disorder: Risk factors and correlatesProg Neuropsychopharmacol Biol Psychiatry200832111517689849
   PubMed Web of Science ®Google Scholar
• RuscioAMSteinDJChiuWTKesslerRCThe epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey ReplicationMol Psychiatry2010151536318725912
   PubMed Web of Science ®Google Scholar
• TorresARPrinceMJBebbingtonPEObsessive-compulsive disorder: Prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000Am J Psychiatry2006163111978198517074950
   PubMed Web of Science ®Google Scholar
• SkoogGSkoogIA 40-year follow-up of patients with obsessive- compulsive disorder [see comments]Arch Gen Psychiatry199956212112710025435
   PubMed Web of Science ®Google Scholar
• SteketeeGEisenJDyckIWarshawMRasmussenSPredictors of course in obsessive compulsive disorderPsychiatry Res199927;893229238
   Web of Science ®Google Scholar
• MenziesLChamberlainSRLairdARThelenSMSahakianBJBullmoreETIntegrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisitedNeurosci Biobehav Rev200832352554918061263
   PubMed Web of Science ®Google Scholar
• MaiaTVCooneyREPetersonBSThe neural bases of obsessive-compulsive disorder in children and adultsDev Psychopathol20082041251128318838041
   PubMed Web of Science ®Google Scholar
• ShihRABelmontePLZandiPPA review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disordersInt Rev Psychiatry200416426028316194760
   PubMed Web of Science ®Google Scholar
• HemmingsSMSteinDJThe current status of association studies in obsessive-compulsive disorderPsychiatr Clin North Am200629241141416650716
   PubMed Web of Science ®Google Scholar
• LeschKPBengelDHeilsAAssociation of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory regionScience199629;274529215271531
   Web of Science ®Google Scholar
• MundoERichterMAZaiG5HT1D beta receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: Further evidence from a family-based association studyMol Psychiatry20027780580912192628
   PubMed Web of Science ®Google Scholar
• GellerDAWielandNCareyKPerinatal factors affecting expression of obsessive compulsive disorder in children and adolescentsJ Child Adolesc Psychopharmacol200818437337918759647
   PubMed Web of Science ®Google Scholar
• MartinoDDefazioGGiovannoniGThe PANDAS subgroup of tic disorders and childhood-onset obsessive-compulsive disorderJ Psychosom Res200967654755719913659
   PubMed Web of Science ®Google Scholar
• BoulougourisVChamberlainSRRobbinsTWCross-species models of OCD spectrum disordersPsychiatry Res200930;17011521
   Web of Science ®Google Scholar
• FinebergNAGaleTMEvidence-based pharmacotherapy of obsessive- compulsive disorderInt J Neuropsychopharmacol20058110712915450126
   PubMed Web of Science ®Google Scholar
• InselTRZoharJBenkelfatCMurphyDLSerotonin in obsessions, compulsions, and the control of aggressive impulsesAnn N Y Acad Sci1990600574585 discussion 585–5862252336
   PubMed Web of Science ®Google Scholar
• PigottTASeaySMA review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorderJ Clin Psychiatry199960210110610084636
   PubMed Web of Science ®Google Scholar
• TolinDFAbramowitzJSDiefenbachGJDefining response in clinical trials for obsessive-compulsive disorder: A signal detection analysis of the Yale-Brown obsessive compulsive scaleJ Clin Psychiatry200566121549155716401156
   PubMed Web of Science ®Google Scholar
• SoomroGMAltmanDRajagopalSOakley-BrowneMSelective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)Cochrane Database Syst Rev2008231CD00176518253995
   PubMed Web of Science ®Google Scholar
• ZaiderTIHeimbergRGFrescoDMSchneierFRLiebowitzMREvaluation of the clinical global impression scale among individuals with social anxiety disorderPsychol Med200333461162212785463
   PubMed Web of Science ®Google Scholar
• Lopez-IborJJJrSaizJCottrauxJDouble-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorderEur Neuropsychopharmacol1996621111188791036
   PubMed Web of Science ®Google Scholar
• KoranLMMcElroySLDavidsonJRRasmussenSAHollanderEJenikeMAFluvoxamine versus clomipramine for obsessive-compulsive disorder: A double-blind comparisonJ Clin Psychopharmacol19961621211298690827
   PubMed Web of Science ®Google Scholar
• MundoERouillonFFigueraMLStiglerMFluvoxamine in obsessive-compulsive disorder: Similar efficacy but superior tolerability in comparison with clomipramineHum Psychopharmacol200116646146812404554
   PubMed Web of Science ®Google Scholar
• BisserbeJLaneRFlamentMA double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorderEuropean Psychiatry1997122829319698511
   PubMed Web of Science ®Google Scholar
• PisaniFOteriGCostaCDi RaimondoGDi PerriREffects of psychotropic drugs on seizure thresholdDrug Saf20022529111011888352
   PubMed Web of Science ®Google Scholar
• MainaGAlbertUSalviVBogettoFWeight gain during longterm treatment of obsessive-compulsive disorder: A prospective comparison between serotonin reuptake inhibitorsJ Clin Psychiatry200465101365137115491240
   PubMed Web of Science ®Google Scholar
• GartlehnerGThiedaPHansenRAComparative risk for harms of second-generation antidepressants: A systematic review and meta-analysisDrug Saf 2008311085186518759509
   PubMed Web of Science ®Google Scholar
• CheetaSSchifanoFOyefesoAWebbLGhodseAHAntidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000Br J Psychiatry2004184414714702226
   PubMed Web of Science ®Google Scholar
• BarbeyJTRooseSPSSRI safety in overdoseJ Clin Psychiatry199859Suppl 1542489786310
   PubMed Web of Science ®Google Scholar
• HemeryckABelpaireFMSelective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An updateCurr Drug Metab2002311311876575
   PubMed Web of Science ®Google Scholar
• SpinaESantoroVD’ArrigoCClinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An updateClin Ther20083071206122718691982
   PubMed Web of Science ®Google Scholar
• GillmanPKTricyclic antidepressant pharmacology and therapeutic drug interactions updatedBr J Pharmacol2007151673774817471183
   PubMed Web of Science ®Google Scholar
• BlochMHMcGuireJLanderos-WeisenbergerALeckmanJFPittengerCMeta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorderMol Psychiatry2009526 [Epub ahead of print]
   Web of Science ®Google Scholar
• HollanderEAllenASteinerMAcute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetineJ Clin Psychiatry20036491113112114628989
   PubMed Web of Science ®Google Scholar
• TollefsonGDRampeyAHJrPotvinJHA multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorderArch Gen Psychiatry19945175595678031229
   PubMed Web of Science ®Google Scholar
• SteinDJAndersenEWTonnoirBFinebergNEscitalopram in obsessive-compulsive disorder: A randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week studyCurr Med Res Opin200723470171117407626
   PubMed Web of Science ®Google Scholar
• NinanPTKoranLMKievAHigh-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: A multicenter double-blind trialJ Clin Psychiatry2006671152216426083
   PubMed Web of Science ®Google Scholar
• PampaloniISivakumaranTHawleyCHigh-dose selective serotonin reuptake inhibitors in OCD: A systematic retrospective case notes surveyJ Psychopharmacol200947 [Epub ahead of print]
   Web of Science ®Google Scholar
• MarchJSFrancesAKahnDACarpenterDThe Expert Consensus Guideline Series: Treatment of obsessive-compulsive disorderJ Clin Psychiatry199758Suppl 4
   Google Scholar
• SteinDJIpserJCBaldwinDSBandelowBTreatment of obsessive-compulsive disorderCNS Spectr2007122 Suppl 3283517277721
   PubMed Web of Science ®Google Scholar
• PallantiSHollanderEBienstockCTreatment non-response in OCD: Methodological issues and operational definitionsInt J Neuropsychopharmacol20025218119112135542
   PubMed Web of Science ®Google Scholar
• RabinowitzIBaruchYBarakYHigh-dose escitalopram for the treatment of obsessive-compulsive disorderInt Clin Psychopharmacol2008231495318090508
   PubMed Web of Science ®Google Scholar
• McDougleCJGoodmanWKLeckmanJFLeeNCHeningerGRPriceLHHaloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without ticsArch Gen Psychiatry19945143023088161290
   PubMed Web of Science ®Google Scholar
• McDougleCJEppersonCNPeltonGHWasylinkSPriceLHA double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorderArch Gen Psychiatry200057879480110920469
   PubMed Web of Science ®Google Scholar
• ErzegovesiSGuglielmoESiliprandiFBellodiLLow-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: A double-blind, placebo-controlled studyEur Neuropsychopharmacol2005151697415572275
   PubMed Web of Science ®Google Scholar
• ShapiraNAWardHEMandokiMA double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorderBiol Psychiatry200455555355515023585
   PubMed Web of Science ®Google Scholar
• BystritskyAAckermanDLRosenRMAugmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: A placebo-controlled trialJ Clin Psychiatry200465456556815119922
   PubMed Web of Science ®Google Scholar
• AtmacaMKulogluMTezcanEGeciciOQuetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: A single-blind, placebo-controlled studyInt Clin Psychopharmacol200217311511911981352
   PubMed Web of Science ®Google Scholar
• DenysDde GeusFvan MegenHJWestenbergHGA double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitorsJ Clin Psychiatry20046581040104815323587
   PubMed Web of Science ®Google Scholar
• CareyPDVythilingumBSeedatSMullerJEvan AmeringenMSteinDJQuetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: A double-blind, randomised, placebo-controlled study [ISRCTN83050762]BMC Psychiatry2005245515667657
   PubMed Web of Science ®Google Scholar
• VulinkNCDenysDFluitmanSBMeinardiJCWestenbergHGQuetiapine augments the effect of citalopram in non-refractory obsessive- compulsive disorder: A randomized, double-blind, placebo-controlled study of 76 patientsJ Clin Psychiatry20097071001100819497245
   PubMed Web of Science ®Google Scholar
• FinebergNASteinDJPremkumarPAdjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: A meta-analysis of randomized controlled treatment trialsInt Clin Psychopharmacol 200621633734317012980
   PubMed Web of Science ®Google Scholar
• McDougleCJBarrLCGoodmanWKLack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorderAm J Psychiatry199515212181218148526253
   PubMed Web of Science ®Google Scholar
• MatsunagaHNagataTHayashidaKOhyaKKiriikeNSteinDJA long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorderJ Clin Psychiatry200970686386819422759
   PubMed Web of Science ®Google Scholar
• SeedatSSteinDJInositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: An open trialInt Clin Psychopharmacol199914635335610565802
   PubMed Web of Science ®Google Scholar
• KoranLMAboujaoudeEBullockKDFranzBGamelNElliottMDouble-blind treatment with oral morphine in treatment-resistant obsessive- compulsive disorderJ Clin Psychiatry200566335335915766302
   PubMed Web of Science ®Google Scholar
• MulaMPiniSCassanoGBThe role of anticonvulsant drugs in anxiety disorders: A critical review of the evidenceJ Clin Psychopharmacol200727326327217502773
   PubMed Web of Science ®Google Scholar
• FallonBALiebowitzMRCampeasRIntravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: A placebo-controlled studyArch Gen Psychiatry199855109189249783563
   PubMed Web of Science ®Google Scholar
• McDougleCJPriceLHGoodmanWKCharneyDSHeningerGRA controlled trial of lithium augmentation in fluvoxamine-refractory obsessive- compulsive disorder: Lack of efficacyJ Clin Psychopharmacol19911131751841820757
   PubMed Web of Science ®Google Scholar
• McDougleCJGoodmanWKLeckmanJFLimited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorderAm J Psychiatry199315046476498465885
   PubMed Web of Science ®Google Scholar
• BarrLCGoodmanWKAnandAMcDougleCJPriceLHAddition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderAm J Psychiatry19971549129312959286191
   PubMed Web of Science ®Google Scholar
• IpserJCCareyPDhansayYFakierNSeedatSSteinDJPharmacotherapy augmentation strategies in treatment-resistant anxiety disordersCochrane Database Syst Rev2006184CD00547317054260
   PubMedGoogle Scholar
• SteinDJDenysDGlosterATObsessive-compulsive disorder: Diagnostic and treatment issuesPsychiatr Clin North Am200932366568519716996
   PubMed Web of Science ®Google Scholar
• CottrauxJBouvardMAMillieryMCombining pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorderCogn Behav Ther200534318519216201063
   PubMedGoogle Scholar
• SimpsonHBFoaEBLiebowitzMRA randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorderAm J Psychiatry2008165562163018316422
   PubMed Web of Science ®Google Scholar
• WilhelmSBuhlmannUTolinDFAugmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorderAm J Psychiatry20081653335341 quiz 40918245177
   PubMed Web of Science ®Google Scholar
• AbramowitzJSTaylorSMcKayDObsessive-compulsive disorderLancet2009374968849149919665647
   PubMed Web of Science ®Google Scholar
• KushnerMGKimSWDonahueCD-cycloserine augmented exposure therapy for obsessive-compulsive disorderBiol Psychiatry200762883583817588545
   PubMed Web of Science ®Google Scholar
• PittengerCKelmendiBWasylinkSBlochMHCoricVRiluzole augmentation in treatment-refractory obsessive-compulsive disorder: A series of 13 cases, with long-term follow-upJ Clin Psychopharmacol200828336336718480706
   PubMed Web of Science ®Google Scholar
• TyeSJFryeMALeeKHDisrupting disordered neurocircuitry: Treating refractory psychiatric illness with neuromodulationMayo Clin Proc200984652253219483169
   PubMed Web of Science ®Google Scholar
• Dell’OssoBAltamuraACAllenAHollanderEBrain stimulation techniques in the treatment of obsessive-compulsive disorder: Current and future directionsCNS Spectr2005101296697916344833
   PubMed Web of Science ®Google Scholar
• MartinJLBarbanojMJPerezVSacristanMTranscranial magnetic stimulation for the treatment of obsessive-compulsive disorderCochrane Database Syst Rev20033CD00338712917964
   PubMedGoogle Scholar
• GreistJHJeffersonJWKobakKAKatzelnickDJSerlinRCEfficacy and tolerability of serotonin transport inhibitors in obsessive- compulsive disorder. A meta-analysisArch Gen Psychiatry199552153607811162
   PubMed Web of Science ®Google Scholar
• PiccinelliMPiniSBellantuonoCWilkinsonGEfficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic reviewBr J Psychiatry199516644244437795913
   PubMed Web of Science ®Google Scholar
• SteinDJSpadacciniEHollanderEMeta-analysis of pharmacotherapy trials for obsessive-compulsive disorderInt Clin Psychopharmacol199510111187622800
   PubMed Web of Science ®Google Scholar
• AbramowitzJSEffectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative reviewJ Consult Clin Psychol199765144529103733
   PubMed Web of Science ®Google Scholar
• KobakKAGreistJHJeffersonJWKatzelnickDJHenkHJBehavioral versus pharmacological treatments of obsessive compulsive disorder: A meta-analysisPsychopharmacology (Berl)199813632052169566805
   PubMed Web of Science ®Google Scholar
• AckermanDLGreenlandSMultivariate meta-analysis of controlled drug studies for obsessive-compulsive disorderJ Clin Psychopharmacol200222330931712006902
   PubMed Web of Science ®Google Scholar